文献速递慢病管理老年与多病共存基层心理健康

超越疾病计数的多病共存测量:社区与人群研究的系统综述及指数选择指南

Measuring multimorbidity beyond counting diseases: systematic review of community and population studies and guide to index choice.
PubMed 文献 · BMJ · 2020-02-18

指数成分包括疾病、诊断类别、药物使用和生理指标,预测结局涵盖死亡、医疗使用、住院和健康相关生活质量,其中12个指数被推荐使用。

要点

  • 现有35个多病共存指数,成分与预测结局各异,研究者应优先评估已有指数适用性。
  • 25个指数以疾病为成分,5个用诊断类别,4个用药物,1个用生理指标。
  • 29个指数涉及心理健康,多数将其作为共病纳入。

核心结论

  • 现有35个多病共存指数可供使用,成分和预测结局不同,研究者和临床医生在创建新指数前应审查现有指数的适用性。

研究设计与样本

  • 纳入描述新多病共存指数且包含比疾病计数更多信息、不聚焦于单一特定疾病共病的原始研究,研究对象为社区或人群水平的成人。
  • 7128条检索结果中识别5560个唯一标题,最终纳入35篇论文。

主要发现

  • 25个指数以疾病为成分(加权或与其他参数组合),5个使用诊断类别,4个使用药物使用,1个使用生理指标。
  • 预测结局包括死亡(18个指数)、医疗使用或费用(13个)、住院(13个)和健康相关生活质量(7个)。
  • 29个指数考虑心理健康的某些方面,大多数将其作为共病纳入。
  • 12个指数被推荐使用。

关键数值与推荐

  • 12个多病共存指数被推荐使用。
  • 18个指数预测死亡,13个预测医疗使用或费用,13个预测住院,7个预测健康相关生活质量。
  • 29个指数涉及心理健康,多数作为共病纳入。

临床怎么用

  • 临床医生和研究者在选择多病共存指数前应审查现有指数的成分和预测结局是否适合其目的。
  • 如需纳入心理健康维度,可优先考虑29个涉及心理健康的指数。

局限性

  • 检索限英文发表,可能遗漏非英文研究。
  • 仅纳入社区或人群水平成人研究,未涵盖其他临床环境。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To identify and summarise existing indices for measuring multimorbidity beyond disease counts, to establish which indices include mental health comorbidities or outcomes, and to develop recommendations based on applicability, performance, and usage. DESIGN: Systematic review. DATA SOURCES: Seven medical research databases (Medline, Web of Science Core Collection, Cochrane Library, Embase, PsycINFO, Scopus, and CINAHL Plus) from inception to October 2018 and bibliographies and citations of relevant papers. Searches were limited to English language publications. ELIGIBILITY CRITERIA FOR STUDY SELECTION: Original articles describing a new multimorbidity index including more information than disease counts and not focusing on comorbidity associated with one specific disease. Studies were of adults based in the community or at population level. RESULTS: Among 7128 search results, 5560 unique titles were identified. After screening against eligibility criteria the review finally included 35 papers. As index components, 25 indices used conditions (weighted or in combination with other parameters), five used diagnostic categories, four used drug use, and one used physiological measures. Predicted outcomes included mortality (18 indices), healthcare use or costs (13), hospital admission (13), and health related quality of life (7). 29 indices considered some aspect of mental health, with most including it as a comorbidity. 12 indices are recommended for use. CONCLUSIONS: 35 multimorbidity indices are available, with differing components and outcomes. Researchers and clinicians should examine existing indices for suitability before creating new ones. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42017074211.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Stirland LE, González-Saavedra L, Mullin DS, et al. Measuring multimorbidity beyond counting diseases: systematic review of community and population studies and guide to index choice. BMJ. 2020. PMID: 32071114. doi:10.1136/bmj.m160

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。